GlassScriptPhysician profile
Gary P Symkoviak
NPI 1841273844
$3,289.61
in general payments reported to CMS, 2019-2025
19 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,680 · 2020: $1,212 · 2021: $398.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $725.83 | 2019-2021 | |
| Amgen INC. | $629.84 | 2019-2021 | |
| Amarin Pharma, INC. | $335.15 | 2019-2021 | |
| Boston Scientific Corporation | $329.01 | 2019-2021 | |
| Janssen Pharmaceuticals, INC | $278.64 | 2019-2020 | |
| Sanofi-Aventis U.S. LLC | $163.63 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $154.21 | 2019-2021 | |
| Lundbeck LLC | $153.13 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $105.93 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $87.23 | 2019-2021 | |
| Esperion Therapeutics, INC. | $79.30 | 2020-2021 | |
| Arbor Pharmaceuticals, INC. | $44.05 | 2019-2021 | |
| Medicure Pharma INC. | $40.24 | 2021 | |
| Gilead Sciences, INC. | $34.07 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $33.13 | 2019 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $30.90 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $28.60 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $23.40 | 2020 | |
| Aegerion Pharmaceuticals, INC. | $13.32 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gary Symkoviak listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.